Improved longevity and functionality of a canine model providing portal vein and multi-site intestinal access

Comparative Medicine

Volumn 50, Issue 2, 2000, Pages 167-174

  Sutyak, John P ^a   Lee, Yong Hee ^b   Perry, Barbara A ^a   Stern, William ^c   Makhey, Vijaya ^b   Sinko, Patrick J ^b,d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Unigene Laboratories Incorporated   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; FIRST PASS EFFECT; INTESTINE ABSORPTION; LIVER METABOLISM; LONGEVITY; NONHUMAN; PORTAL VEIN; STOMACH EMPTYING; SYSTEMIC CIRCULATION; VASCULAR ACCESS;

ANIMALS; CATHETERS, INDWELLING; COLON; DIMETHYLPOLYSILOXANES; DOGS; DUODENUM; FILTRATION; ILEUM; INTESTINAL ABSORPTION; MALE; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PORTAL VEIN; SEPSIS; SILICONES; VASCULAR SURGICAL PROCEDURES;

EID: 0034088941     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dressman, J. B., P. Bass, W. A. Ritschel, et al. 1993. Gastrointestinal parameters that influence oral medications. J. Pharm. Sci. 82:857-872.
2. Aungst, B. J. 1993. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82:979-987.
3. Yuasa, H., K. Matsuda, and J. Watanabe. 1993. Influence of anesthetic regimens on intestinal absorption in rats. Pharm. Res. 10:884-688.
4. Zinner, M. J., D. Sherlock, and A. Ferrara, et al. 1985. Verapamil inhibition of the intestinal effects of substance P. Surgery 98:230-235.
5. Kukan, M., S. Bezek, T. Trnovec, et al. 1994. On the absorption of drugs using chronic dog ileal loop method. Methods Find. Exp. Clin. Pharmacol. 16:437-442.
6. Taylor, D. C., R. Grundy, and B. Loveday. 1981. Chronic dog intestinal loop model for studying drug absorption as exemplified by b-adrenoreceptor blocking agents, atenolol and propranolol. J. Pharm. Sci. 70:516-521.
7. Meunier, L. D., J. T. Kissinger, J. Maercello, et al. 1993. A chronic access port model for direct delivery of drugs into the intestine of conscious dogs. Lab. Anim. Sci. 43:466-470.
8. Kwei, G. Y., J. R. Gehret, L. B. Novak, et al. 1995. Chronic catheterization of the intestines and portal vein for absorption experimentation in beagle dogs. Lab. Anim. Sci. 45:683-685.
9. Zollinger, R. M. Jr., and R. M. Zollinger (eds.). 1988. Witzel enterostomy, p. 114-115. In Atlas of surgical operations. Macmillan Publishing Co., New York.
10. Stevenson, G. W. 1989. Gastrointestinal tract physiology, p. 280, and Odo Op Den Orth, J. Duodenum, p. 659. In A. R. Margulis, and H. J. Burhenne (eds.), Alimentary tract radiology. CV Mosby Co. Press, Baltimore.
11. Stevenson, G. W. 1989. Gastrointestinal tract physiology, p. 280, and Odo Op Den Orth, J. Duodenum, p. 659. In A. R. Margulis, and H. J. Burhenne (eds.), Alimentary tract radiology. CV Mosby Co. Press, Baltimore.
12. Sinko, P. J., J. P. Sutyak, G. D. Leesman, et al. 1997. Oral absorption of anti-AIDS nucleotide analogues: 3. Regional absorption and in vivo permeability of 2′,3′-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model. Biopharm. Drug Dispos. 18:697-710.
13. Sinko, P. J., Y. H. Lee, V. Makhey, et al. 1999. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems. In vitro permeability and in vivo oral absorption of salmon calcitonin (sCT). Pharm. Res. 16:527-533.
14. Saffran, M., G. S. Kumar, C. Savariar, et al. 1986. A new approach to the oral administration of insulin and other peptide drugs. Science 233:1081-1084.
15. Mrsny, R. N. 1992. The colon as a site for drug delivery. J. Controlled Rel. 22:15-34.